Samsung Biologics Joins WHO Workforce Training... Headquarters Tour Conducted for Young Trainees

More than 30 trainees from the WHO Global Bio Workforce Development Hub are taking a commemorative photo after touring the Samsung Biologics headquarters located in Songdo, Incheon.

[Asia Economy Reporter Lee Gwan-joo] Samsung Biologics announced on the 25th that it conducted a tour of its headquarters in Songdo, Incheon, for trainees of the World Health Organization (WHO) Workforce Training Hub.

In February, South Korea was designated by the WHO as a 'Global Bio Workforce Training Hub' for training in vaccine and biopharmaceutical production processes, and education is currently being conducted under the supervision of the International Vaccine Institute (IVI).

Education has been provided by Samsung Biologics, Celltrion, GC Noksimja, Sartorius, Cytiva, Seoul National University, Yonsei University, Korea University, and Seoul National University Clinical Trial Center. A total of 106 production personnel from 25 low- and middle-income countries and 32 domestic trainees participated in the training.

As a private partner institution, Samsung Biologics introduced the process facilities and exhibition hall of the world's largest biopharmaceutical production plant located in Songdo to about 30 trainees, joining efforts to nurture talent.

This content was produced with the assistance of AI translation services.